<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T11:50:56Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/5902" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/5902</identifier><datestamp>2024-06-06T13:28:20Z</datestamp><setSpec>com_2072_378071</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378097</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma</dc:title>
   <dc:creator>Almazan Moga, Ana</dc:creator>
   <dc:creator>Zarzosa Martinez, Patricia</dc:creator>
   <dc:creator>Vidal Marin, Isaac</dc:creator>
   <dc:creator>Molist Muñoz, Carla</dc:creator>
   <dc:creator>Giralt Buch, Irina</dc:creator>
   <dc:creator>Soriano Fernández, Aroa</dc:creator>
   <dc:creator>Segura Ginard, Miguel</dc:creator>
   <dc:creator>Sánchez de Toledo Codina, Josep</dc:creator>
   <dc:creator>Roma Castanyer, Josep</dc:creator>
   <dc:creator>Gallego Melcón, Soledad</dc:creator>
   <dc:creator>Navarro Barea, Natalia</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Almazán-Moga A, Zarzosa P, Vidal I, Molist C, Giralt I, Navarro N, Soriano A, Segura MF, Roma J] Grup de Recerca translacional en càncer infantil, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Barcelona, Spain. [Sánchez de Toledo J, Gallego S] Grup de Recerca translacional en càncer infantil, Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Oncologia i Hematologia Pediàtriques, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Tumors de parts toves</dc:subject>
   <dc:subject>Cèl·lules canceroses</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms, Muscle Tissue::Myosarcoma::Rhabdomyosarcoma</dc:subject>
   <dc:subject>ANATOMY::Cells::Stem Cells::Neoplastic Stem Cells</dc:subject>
   <dc:subject>DISEASES::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma::Myosarcoma::Rhabdomyosarcoma</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias de tejido muscular::miosarcoma::rabdomiosarcoma</dc:subject>
   <dc:subject>ANATOMÍA::células::células madre::células madre neoplásicas</dc:subject>
   <dc:subject>ENFERMEDADES::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::neoplasias::neoplasias por tipo histológico::neoplasias de tejido conjuntivo y de tejidos blandos::sarcoma::miosarcoma::rabdomiosarcoma</dc:subject>
   <dc:description>Tumors dels teixits tous; Via Hedgehog; Rabdomiosarcoma</dc:description>
   <dc:description>Tumores de los tejidos blandos; Vía Hedgehog; Rabdomiosarcoma</dc:description>
   <dc:description>Soft tissue neoplasms; Hedgehog pathway; Rhabdomyosarcoma</dc:description>
   <dc:description>Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children and can be divided into two main subtypes: embryonal (eRMS) and alveolar (aRMS). Among the cellular heterogeneity of tumors, the existence of a small fraction of cells called cancer stem cells (CSC), thought to be responsible for the onset and propagation of cancer, has been demonstrated in some neoplasia. Although the existence of CSC has been reported for eRMS, their existence in aRMS, the most malignant subtype, has not been demonstrated to date. Given the lack of suitable markers to identify this subpopulation in aRMS, we used cancer stem cell-enriched supracellular structures (spheres and holoclones) to study this subpopulation. This strategy allowed us to demonstrate the capacity of both aRMS and eRMS cells to form these structures and retain self-renewal capacity. Furthermore, cells contained in spheres and holoclones showed significant Hedgehog pathway induction, the inhibition of which (pharmacologic or genetic) impairs the formation of both holoclones and spheres. Our findings point to a crucial role of this pathway in the maintenance of these structures and suggest that Hedgehog pathway targeting in CSC may have great potential in preventing local relapses and metastases.</dc:description>
   <dc:description>The authors wish to thank Dr. Noel Monks (MedImmune) for the kind gift of the blocking antibody MEDI-5304 and Ms. Christine O’Hara for help with the English version of this manuscript. This work was supported by grants from Institut Català d’Oncologia (ICO), Instituto de Salud Carlos III (RTICC-RD12/0036/0016 and RD12/0036/0027; PI11/00740 and PI14/00647), Fundació A. BOSCH, and ajuts predoctorals VHIR.</dc:description>
   <dc:date>2021-04-22T11:29:00Z</dc:date>
   <dc:date>2021-04-22T11:29:00Z</dc:date>
   <dc:date>2017-01-24</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Almazán-Moga A, Zarzosa P, Vidal I, Molist C, Giralt I, Navarro N, et al. Hedgehog Pathway Inhibition Hampers Sphere and Holoclone Formation in Rhabdomyosarcoma. Stem Cells Int. 2017;2017:7507380.</dc:identifier>
   <dc:identifier>1687-9678</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/5902</dc:identifier>
   <dc:identifier>10.1155/2017/7507380</dc:identifier>
   <dc:identifier>28243259</dc:identifier>
   <dc:identifier>000394217900001</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Stem Cells International;2017</dc:relation>
   <dc:relation>https://www.hindawi.com/journals/sci/2017/7507380/</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/1PN/2008-2011/RD12%2F0036%2F0016</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/2PN/2008-2011/PI11%2F00740</dc:relation>
   <dc:relation>info:eu-repo/grantAgreement/ES/PE2013-2016/PI14%2F00647</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Hindawi</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>